An Analytical Reference Standard
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

γ-Butyrolactone

Item No. 18706

Synonyms
Synonyms
  • GBL
  • γ-Hydroxybutyric Acid lactone
  • NIH 10540
  • NSC 4592
Technical Information
Formal Name
dihydro-2(3H)-furanone
CAS Number
96-48-0
Molecular Formula
C4H6O2
Formula Weight
Purity
≥95%
Formulation
A solution in acetonitrile
DMF: 10 mg/mlDMSO: 10 mg/mlEthanol: 10 mg/mlPBS (pH 7.2): 1 mg/ml
SMILES
O=C1CCCO1
InChi Code
InChI=1S/C4H6O2/c5-4-2-1-3-6-4/h1-3H2
InChi Key
YEJRWHAVMIAJKC-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Cayman Spectral Library

    Our free, searchable, GC-MS spectral database contains 70eV EI mass spectral data of 2,000+ of Cayman’s forensic drug standards.

    DOWNLOAD THE DATABASE
    Product Description

    γ-Butyrolactone (Item No. 18706) is an analytical reference standard categorized as a prodrug form of GHB (Item No. 9002506).1,2 γ-Butyrolactone is commonly used as a solvent and reagent in chemistry applications.1,2,3 γ-Butyrolactone is regulated as a List I chemical in the United States. This product is intended for research and forensic applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Winstock, A.R., and Mitcheson, L. New recreational drugs and the primary care approach to patients who use them. BMJ 344, e288 (2012).

    2. Busardò, F.P., and Jones, A.W. GHB pharmacology and toxicology: Acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Curr. Neuropharmacol. 13(1), 47-70 (2015).

    3. Justice, U.S.D.o. GHB Analogs. 2002-L0424-003, (2002).